Eukaryotic ribosome display for antibody discovery: A review
Human Antibodies · 2024
DOI: 10.3233/hab-240001 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Human Antibodies, 2024. Verfasst von Randy Chance und 1 weiteren Autor:innen. Hauptthemen laut MEDLINE: Ribosomes, Antibodies, Monoclonal, Peptide Library. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 123 Literaturangaben.
Abstract (Originalsprache)
Monoclonal antibody biologics have significantly transformed the therapeutic landscape within the biopharmaceutical industry, partly due to the utilisation of discovery technologies such as the hybridoma method and phage display. While these established platforms have streamlined the development process to date, their reliance on cell transformation for antibody identification faces limitations related to library diversification and the constraints of host cell physiology. Cell-free systems like ribosome display offer a complementary approach, enabling antibody selection in a completely in vitro setting while harnessing enriched cellular molecular machinery. This review aims to provide an overview of the fundamental principles underlying the ribosome display method and its potential for advancing antibody discovery and development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Zitieren
APA
Chance, R., & Kang, A. S. (2024). Eukaryotic ribosome display for antibody discovery: A review. Human Antibodies. https://doi.org/10.3233/hab-240001
Vancouver
Chance R, Kang AS. Eukaryotic ribosome display for antibody discovery: A review. Human Antibodies. 2024. doi:10.3233/hab-240001
BibTeX
@article{Chance2024,
author = {Chance, Randy and Kang, Angray Singh},
title = {Eukaryotic ribosome display for antibody discovery: A review},
journal = {Human Antibodies},
year = {2024},
doi = {10.3233/hab-240001}
}
EUVIMED